Medicine chest (idiom)

Last updated

Medicine chest or medicine cabinet is a colloquial phrase and idiom used to describe an area with the highest concentration of medicine stockpile, production, or potential of sources for medicines. The phrase is used with the area to specify the scope, such as world's medicine chest or nation's medicine cabinet. [1]

Contents

Rainforests

In nature, tropical rainforests are considered the world's medicine chest [2] or world's largest pharmacy as 25% of Western pharmaceuticals are derived from ingredients found in tropical rainforests. [3] Additionally, more than 2,000 plants from the tropical rainforests have been identified as having anti-cancer properties with 70% of those are found only in rainforests. There are additional potential to this medicine chest. Currently, only less than 1% of all species in rainforests have been analysed for their medicinal value. [4]

Pharmaceutical industry

Germany and Europe

In pharmaceutical industry, Germany was considered the world's medicine cabinet in late 20th century after German firms invented the pharmaceutical industry in the late 19th and early 20th centuries and recovered from the World War II. During the 1970s, the major pharmaceutical companies were concentrated in France, Germany, Switzerland and the United Kingdom with 55% of world's medicine production by major nation came from those countries. That gave the European pharmaceutical industry the world's medicine chest title until the 1990s. In 1990, the pharmaceutical companies in Europe outspent the upcoming American companies in research and development by 8 billion Euros to 5 billion Euros. However, in the period of 10 years, American companies had reversed the trend by investing more in research and development of medicines which outspent European companies by 24 billion Euros to 17 billion Euros in 2000. As a result, some major companies started to relocate operation, research and other divisions including headquarters to the United States. [5] [6]

New Jersey

As the pharmaceutical industry in the United States expanded in the 21st century, New Jersey has become the state with more pharmaceutical companies than any other U.S. state, and known to be the world's medicine chest. [7] In 2006, three of top ten pharmaceutical companies in the world were headquartered in New Jersey. [8]

In 2011, New Jersey was home to world or North American headquarters for 17 of the 20 largest pharmaceutical companies in the world. The state was ranked 6th in the nation in biotech, 3rd in bioscience venture capital investments and 4th in the number of bioscience patents. The growth of biotechnology companies in the state between 2008 and 2011 were increased more than 50% to have more than 300 biotech companies. [9]

As of 2012, two of the top ten companies are based in New Jersey [10] after Wyeth was acquired by New York-based firm, Pfizer in 2009. [11]

Stockpiling

In emergency management, when government entities stockpile essential medicines to be used in case of major emergencies, it can be said to be restocking the nation's emergency medicine chest. An example of such stockpiles is Strategic National Stockpile in the United States. [12]

See also

Related Research Articles

Pfizer American multinational pharmaceutical corporation

Pfizer Inc. is an American multinational pharmaceutical corporation headquartered in New York City. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biopharmaceutical company. In 2013, it moved its headquarters to Cambridge, United Kingdom, and concentrated its R&D in three sites: Cambridge; Gaithersburg, Maryland, USA for work on biopharmaceuticals; and Mölndal in Sweden, for research on traditional chemical drugs. AstraZeneca has a portfolio of products for major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation.

Merck KGaA, branded and commonly known as Merck, is a German multinational pharmaceutical, chemical and life sciences company headquartered in Darmstadt, with about 56,000 employees and present in 66 countries. Merck was founded in 1668 and is the world's oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies in the world.

Shire Plc was a Jersey-registered specialty biopharmaceutical company. Originating in the United Kingdom with an operational base in the United States, its brands and products included Vyvanse, Lialda, and Adderall XR. Shire was acquired by Takeda Pharmaceutical Company on 8 January 2019.

Pharmacia & Upjohn

Pharmacia & Upjohn was a global pharmaceutical company formed by the merger of Sweden-based Pharmacia AB and the American company Upjohn in 1995. Today the remainder of the company is owned by Pfizer. In 1997, Pharmacia & Upjohn sold several brands to Johnson & Johnson, including Motrin and Cortaid.

The pharmaceutical industry in India was valued at US$33 billion in 2017 and generic drugs account for 20 per cent of global exports in terms of volume, making the country the largest provider of generic medicines globally. According to the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, domestic pharmaceutical market turnover reached Rs 129,015 crore in 2018, growing 9.4 per cent year-on-year and exports revenue was US$17.28 billion in FY18 and US$19.14 billion in FY19. Hyderabad, Mumbai, Bangalore, Ahmedabad, Vadodara, Ankleshwar and Sikkim are the major pharmaceutical hubs of India.

American Cyanamid Company was a leading American conglomerate which became one of the nation's top 100 manufacturing companies during the 1970s and 1980s, according to the Fortune 500 listings at the time. Founded by Frank Washburn in 1907, the company grew to over 100,000 employees worldwide, and had over 200,000 shareholders by the mid-1970s. Its stock was traded on the New York Stock Exchange under the symbol ACY. It was repeatedly reorganized after the mid-1990s, merged with other firms, and saw brands and divisions sold or spun off. The bulk of the former company is now part of Pfizer, with smaller portions belonging to BASF, Procter & Gamble and other firms.

Celltech

Celltech Group plc was a leading British-based biotechnology business based in Slough. It was listed on the London Stock Exchange and was a constituent of the FTSE 100 Index.

Jeffrey B. Kindler is an American healthcare executive and private investor. He served as chairman and CEO of the pharmaceutical company Pfizer from 2006 to 2010. Kindler has later served as CEO of Centrexion Inc., and chairman of the GLG Institute.

Peter Rost (doctor) Swedish whistleblower

Peter Rost, M.D. is a former drug marketing executive and is most known for taking public stances critical of the pharmaceutical industry as an "insider" and whistleblower. He sued his last two pharmaceutical employers, Wyeth and Pfizer, the latter of which fired him in 2005. At Wyeth, he uncovered tax evasion practices, and after informing senior company executives, was transferred from Sweden to a post in New Jersey. Rost sued the company, saying that the transfer was a retaliatory demotion, though the company said it was a promotion. Rost settled with Wyeth for an undisclosed amount in 2003. At Pfizer, Rost filed a qui tam suit disclosing off-label marketing of Genotropin at Pharmacia prior to its purchase by Pfizer. The U.S. Department of Justice declined to join in Rost's suit as the marketing violations had already been disclosed to the Department by Pfizer. Rost was eventually fired by Pfizer, and sued for wrongful dismissal, but this lawsuit was summarily dismissed by the court based on evidence that Pfizer had decided to fire Rost prior to discovery of his whistleblowing activities. Since then, Rost has worked outside the pharmaceutical industry, as a public speaker, blogger, writer, and litigation consultant.

Sid Martin Biotechnology Incubator

UF Innovate | Sid Martin Biotech is located in Alachua, Florida, in Progress Park. The program's mission is to foster the growth of bioscience startup companies that have some relationship to the University. The Incubator works with companies in all product areas relating to the life sciences, biomedical research, medicine, and chemical sciences.

The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services office responsible for procurement and development of countermeasures principally against bioterrorism, but also including chemical, nuclear and radiological threats as well as pandemic influenza and emerging diseases. BARDA reports to the Office of the Assistant Secretary for Preparedness and Response and manages Project BioShield. BARDA also procures materials, such as vaccines, for the Strategic National Stockpile, and more broadly is an established interface between the U.S. Government and the biomedical industry. BARDA also manages the governmental inter-agency Public Health Emergency Medical Countermeasures Enterprise, providing coordination across the government in development and deployment of such countermeasures.

The pharmaceutical industry in the United Kingdom directly employs around 73,000 people and in 2007 contributed £8.4 billion to the UK's GDP and invested a total of £3.9 billion in research and development. In 2007 exports of pharmaceutical products from the UK totalled £14.6 billion, creating a trade surplus in pharmaceutical products of £4.3 billion.

Wyeth defunct pharmaceutical company

Wyeth, LLC was an American pharmaceutical company. The company was founded in Philadelphia, Pennsylvania, in 1860 as John Wyeth and Brother. It was later known as American Home Products before being renamed to Wyeth in 2002. Its headquarters moved to Collegeville, Pennsylvania, and Madison, New Jersey, before its headquarters were consolidated with Pfizer's in New York City after the 2009 merger. Most of Wyeth's pharmaceutical assets were acquired by Pfizer in 2009, while its infant and maternal nutrition business was acquired by Nestlé in 2012.

Ohio bioscience sector ranked #4 among USA states in 2008 by Business Facilities magazine

The Ohio bioscience sector strength was ranked #4 among USA states in 2008 by Business Facilities magazine.

The Coalition for Epidemic Preparedness Innovations (CEPI) is a foundation that takes donations from public, private, philanthropic, and civil society organisations, to finance independent research projects to develop vaccines against emerging infectious disease (EID). CEPI is focused on the World Health Organisation's (WHO) "blueprint priority diseases", which includes: the Middle East respiratory syndrome-related coronavirus (MERS-CoV), the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the Nipah virus, the Lassa fever virus, and the Rift Valley fever virus, as well as the Chikungunya virus and the hypothetical, unknown pathogen "Disease X". CEPI investment also requires "equitable access" to the vaccines during outbreaks.

Biotechnology industry in Boston overview sbout the biotechnology industry in Boston

Greater Boston, primarily Boston and Cambridge, is home to almost 1,000 biotechnology companies, ranging from small start-ups to billion-dollar pharmaceutical companies. The many universities in the area give the region a large network of scientists.

On 23 April 2012, Nestlé agreed to acquire Pfizer Inc.'s infant-nutrition, formerly Wyeth Nutrition, unit for US$11.9 billion, topping a joint bid from Danone and Mead Johnson.Nestle Wyeth Nutrition provides food products to meet the needs of infants, young children and adults. Through scientific research,they claim to help nourish children when breastfeeding is not an option. Wyeth Nutrition started in 1915 when Henry Grestberger manufactured the first formula patterned after breast milk called SMA. Wyeth Pharmaceuticals, formerly Wyeth-Ayerst Laboratories, is the original company founded by the Wyeth brothers, originally known as John Wyeth and Brother. They focused on the research, development, and marketing of prescription drugs. The pharmaceuticals division was further subdivided into five subdivisions: Wyeth Research, Prescription Products, Biotech, Vaccines, and Nutritionals. Wyeth's research and development director Robert Ruffolo was quoted in The New York Times about the firm's efforts to develop new drugs.

References

  1. ↑ Todd, Susan (25 January 2011). "N.J.'s pharmaceutical industry group gets new president". The Star-Ledger. Retrieved 21 February 2013.
  2. ↑ Moore, Bill. "Rainforests, National Security and Tomorrow's Economy". EV World. Retrieved 21 February 2013.
  3. ↑ Evans, Michael. "Rainforests". Earth Times. Retrieved 21 February 2013.
  4. ↑ "Facts about Rainforests". The Nature Conservancy. Archived from the original on 22 October 2015. Retrieved 21 February 2013.
  5. ↑ John, Lechleiter. "An Internal Failure To Innovate Is America's Greatest Global Threat (Op/Ed)". Forbes. Retrieved 21 February 2013.
  6. ↑ "Why the Germany and Much of the European Union is Losing its Pharmaceutical Industry" (PDF). American Enterprise Institute. Archived from the original (PDF) on 9 July 2013. Retrieved 21 February 2013.
  7. ↑ "Regional Assets". Discover Philadelphia. Archived from the original on 1 August 2014. Retrieved 21 February 2013.
  8. ↑ Gray, Nicole (May 2006). "A Special Report on the World's Top 50 Pharma Companies" (PDF). Pharmaceutical Executive. Archived from the original (PDF) on 24 March 2012. Retrieved 21 February 2013.
  9. ↑ "Strengths, Assets and Challenges" (PDF). State Planning. New Jersey State. Retrieved 21 February 2013.
  10. ↑ "Pharm Exec 50: Growth from the Bottom Up". Pharmaceutical Executive. 1 May 2012. Retrieved 21 February 2013.
  11. ↑ "Wyeth Transaction". Pfizer. Archived from the original on 19 October 2009. Retrieved 21 February 2013.
  12. ↑ Park, Alice (29 April 2009). "How Fast Could a Swine Flu Vaccine Be Produced?". TIME. Retrieved 21 February 2013.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.